执笔作者机构:[1]Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China.[2]Shandong Province Cancer Hospital, Ji'nan, China.[3]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.[4]Beijing Cancer Hospital, China.[5]Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.[6]Daping Hospital, The Third Military Medical University, Chongqing, China.[7]Yunnan Province Cancer Hospital, Kunming, China.[8]Beijing Hospital, China.[9]Peking Union Medical College Hospital, China.[10]Beijing Xuanwu Hospital, Capital Medical University, China.[11]West China Hospital of Sichuan University, Chengdu, China.[12]Jiangsu Cancer Hospital, Nanjing, China.[13]The First Hospital of China Medical University, Shenyang, China.[14]The 307th Hospital of Chinese People's Liberation Army, China.[15]Huazhong University of Science and Technology Union Hospital, Wuhan, China.[16]Chinese People's Liberation Army General Hospital, China.[17]The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.[18]The First Hospital of Jilin University, Changchun, China.[19]Harbin Medical University Cancer Hospital, Harbin, China.[20]Xinqiao Hospital of The Third Military Medical University, Chongqing, China.[21]Sichuan Cancer Hospital, Chengdu, China.[22]Department of Imaging Diagnostic, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China.[23]Qinghai University Affiliated Hospital, Xining, China.[24]The First Affiliated Hospital of Chinese People's Liberation Army General Hospital, China.[25]Zhejiang Cancer Hospital, Hangzhou, China.[26]Beijing Chest Hospital, Capital Medical University, Beijing, China.[27]Henan Province Cancer Hospital, Zhengzhou, China.[28]Shanxi Province Cancer Hospital, Taiyuan, China.[29]Nanfang Hospital, Nanfang Medical University, Guangzhou, China.[30]Cancer Hospital of Xinjiang Medical University, Urumqi, China.[31]Shanghai Pulmonary Hospital, Tongji University, China.[32]The First Affiliated Hospital, Zhejiang University, Hangzhou, China.[33]Xiangya Hospital, Central South University, Changsha, China.[34]Cancer Hospital, Fudan Universitay, Shanghai, China.[35]Fujian Cancer Hospital, Fuzhou, China.[36]Shanghai Chest Hospital, Shanghai Jiaotong University, China.
Yuankai SHI,Yan SUN,Jinming YU,et al.China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)[J].ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY.2017,13(1):87-103.
APA:
Yuankai SHI,Yan SUN,Jinming YU,Cuimin DING,Ziping WANG...&Yuankai Shi.(2017).China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version).ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY,13,(1)
MLA:
Yuankai SHI,et al."China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)".ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 13..1(2017):87-103